Quantcast
Last updated on April 19, 2014 at 12:41 EDT

StockCall Pre-Market Review on Hologic, St. Jude Medical, ResMed, and Navidea Biopharma

March 15, 2013

LONDON, March 15, 2013 /PRNewswire/ –

Markets continued their ascent as The Dow Jones closed high for the tenth consecutive
day. Major indices including S&P and NASDAQ also ended the session in the green zone.
While a report alluded to the ‘flare up’ in housing foreclosures, strong job data provided
positive fillip to the markets. However, with the sharp rise in the market, skepticism is
also taking hold as a leading financial expert Kerry Balenthiran warned that the markets
may turn bearish this year. Our research team took a look at Healthcare sector, more
specifically the Medical Appliances & Equipment industry which includes major companies
like Hologic Inc. (NASDAQ: HOLX), St. Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE:
RMD) and Navidea Biopharmaceuticals Inc. (NYSE: NAVB). StockCall analysts initiated
preliminary technical research on HOLX, STJ, RMD, and NAVB. These free reports are
accessible by signing today at

http://www.stockcall.com/register

Hologic Inc. extended its 52 weeks gain by closing 0.99 percent higher. The stock
ended its Thursday session at $22.46, while its highest price point for yesterday’s
session stood at $22.47. It traded 1.18 million shares, down from its average daily volume
high of 2.80 million. The medical equipment maker traded in the range of $16.18 and $23.96
in the past 52 weeks and currently it is trading near its high price point. The company
commands market capitalization of $6.01 billion and it reported its latest EPS at -$0.35.
Hologic Inc. stock gained more than 6 percent in the past 52 weeks. The free technical
analysis on HOLX is available by signing up at

http://www.StockCall.com/HOLX031513.pdf

St. Jude Medical Inc. slipped marginally with lower volume to end its latest session
at $42.90. The stock ended 0.21 percent lower than its previous close. Its volume for the
day stood at 2.15 million shares. The stock is currently trading higher than its 20-day
SMA of $42.89 but lower than its 50-day SMA of $42.91, showing a neutral trend. Its first
resistance level is at $43.05 while it may tumble to $42.65 before receiving any support.
St. Jude Medical’s stock is up 20.95 percent on a YTD basis, while offering 2.14 percent
dividend yield. Register now to download the free research on STJ at

http://www.StockCall.com/STJ031513.pdf

ResMed Inc. ended yesterday’s trading session at $43.74, up 0.81 percent from its
previous close. With its latest upward move, the stock is now up 6.92 percent on a YTD
basis, while its 52 weeks gain stands at 45.9 percent. The company oscillated in the range
of $43.27 and $43.81 during Thursday’s session. It traded 958, 085 shares and showed a
mild bullish trend. The stock may touch $43.95 in the coming sessions. Upon breaching this
level, its next resistance level is at $44.25. Free report on RMD can be accessed by
registering at

http://www.StockCall.com/RMD031513.pdf

Navidea Biopharmaceuticals Inc. sank in Thursday’s session. The stock closed 7.91
lower at $2.91 with above average volume of 4.08 million shares, showing a bearish trend.
The company has its first support level at $2.75. Upon breaching this level, its next
support level is at $2.56. Navidea Biopharma is currently trading near its 52 weeks low of
$2.14, while its 52 weeks high stands at $4.77. The company commands market capitalization
of 312.51 million. The company is also trading below its short-term and long-term average
price, further confirming a bearish trend. Register with StockCall and download the
research on NAVB for free at

http://www.StockCall.com/NAVB031513.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and
comprehensive research and opinions on stocks making the headlines. Sign up today to talk
to our financial analyst at

http://www.stockcall.com

SOURCE StockCall.com


Source: PR Newswire